Author details

Full Name

Sharon G Adler

Affiliation

ORCID

Career Start Year

1983

Papers

144

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36681522	Chronic interstitial nephritis in agricultural communities and pre-eclampsia: Is there a link?		2023
35946050	Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model.	Peritoneal Dialysis International	2023
36442540	Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.	Kidney Int	2023
37915862	The International Society of Glomerular Disease: Building the Future of Glomerular Medicine.		2023
34166655	Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy.	Am J Ophthalmol	2022
36239062	Diabetic kidney disease treatment: new perspectives.	Kidney Research and Clinical Practice	2022
36006643	Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.	JAMA Netw Open	2022
36268164	Erratum: Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits-The Hispanic/Latino Anthropometry Consortium.	HGG Adv	2022
35659450	Erratum to Gene Set Enrichment Analyses Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy. Am J Ophthalmol 2022;233:111-123.	Am J Ophthalmol	2022
35399580	Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits-The Hispanic/Latino Anthropometry Consortium.	HGG Adv	2022
34556300	Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.	Kidney Int	2021
36751494	Association between Psychiatric Disorders and Glomerular Disease.	Glomerular Dis	2021
36751487	Gaining Ground in Glomerular Diseases.		2021
33646395	APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.	Pediatr Nephrol	2021
34337593	Kidney Injury Molecule-1 and Periostin Urinary Excretion and Tissue Expression Levels and Association with Glomerular Disease Outcomes.	Glomerular Dis	2021
32734234	Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.	Kidney Med	2020
30487263	Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.	Diabetes	2019
31891002	Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease.	Kidney Int Rep	2019
32905199	The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network.	Clin Kidney J	2019
29481660	JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.	Nephrol Dial Transplant	2018
29046291	Diabetic Kidney Disease.	Clinical journal of the American Society of Nephrology : CJASN	2018
30361325	DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.	J Am Soc Nephrol	2018
29981754	Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome.	Exp Mol Pathol	2018
29667921	Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.		2018
27729571	Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study.	J Am Soc Nephrol	2017
29142983	Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).	Kidney Int Rep	2017
29340321	Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.	Kidney Int Rep	2017
29725648	NephCure Accelerating Cures Institute: AÂ Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome.	Kidney Int Rep	2017
27528553	The relatively poor correlation between random andÂ 24-hour urine protein excretion in patients withÂ biopsy-proven glomerular diseases.	Kidney Int	2016
27019421	Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial.	PLoS ONE	2016
26799652	Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).	Autophagy	2016
27142425	Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND).	BMC Genomics	2016
26656320	Complete Remission in the Nephrotic Syndrome Study Network.	Clin J Am Soc Nephrol	2016
27536666	Prevalence and Management of Diabetic Nephropathy in Western Countries.		2015
26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	PLoS Genet	2015
26577187	Strategy and rationale for urine collection protocols employed in the NEPTUNE study.	BMC Nephrol	2015
25007168	Janus kinase signaling activation mediates peritoneal inflammation and injury in vitro and in vivo in response to dialysate.	Kidney International	2014
25378588	Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.	Nephrol Dial Transplant	2014
26894033	Comprehensive approach to diabetic nephropathy.	Kidney Research and Clinical Practice	2014
24651796	Time to look back and to look forward.	Diabetes	2014
23325076	Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.	Kidney Int	2013
24358131	A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).	PLoS One	2013
24057238	Susceptibility gene search for nephropathy and related traits in Mexican-Americans.	Molecular Biology Reports	2013
23615341	Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity.	Retina	2013
22119407	Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.	Am J Kidney Dis	2012
22653259	Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium.	American Journal of Nephrology	2012
22784559	Change in ankle-brachial index over time and mortality in diabetics with proteinuria.	Clinical Nephrology	2012
22449346	Novel insights into the relationship between glomerular pathology and progressive kidney disease.	Advances in Chronic Kidney Disease	2012
22167593	Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.	Nephrology Dialysis Transplantation	2012
21734081	Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin?	Clinical journal of the American Society of Nephrology : CJASN	2011